S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|BioCryst to Announce Second Quarter 2014 Financial Results August 5|
|BioCryst Reports Second Quarter 2014 Financial Results|
|BioCryst Announces Late Breaker Presentation of OPuS-1 Phase 2 Trial Results at the 23rd EADV Congress|
|BioCryst Receives Additional NIAID Funding to Advance Development of BCX4430 to Treat Hemorrhagic Fever Virus Diseases|
|BioCryst Participates in World Health Organization Consultation on Potential Ebola Therapies|
|BioCryst Receives Additional NIAID Funding to Conduct a Non-Human Primate Study of BCX4430 in Ebola Virus Disease|
|BioCryst Receives Additional NIAID Funding for Manufacture and Development of BCX4430 to Treat Hemorrhagic Virus Diseases|
|BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting|
|BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting|
|RAPIVAB(TM) Trial Results for the Treatment of Influenza to be Presented at IDWeek 2014|
Click above to view more mutual fund data and stats for bcrx - Biocryst Pharmaceuticals Inc.